Repeat pap testing and colposcopic biopsies in the underserved

Obstetrics and Gynecology

Volumn 114, Issue 5, 2009, Pages 1049-1056

  Trivers, Katrina F ^a   Benard, Vicki B ^a   Eheman, Christie R ^a   Royalty, Janet E ^a   Ekwueme, Donatus U ^a   Lawson, Herschel W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; CANCER DIAGNOSIS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HISPANIC; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOPSY; COLPOSCOPY; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; ODDS RATIO; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 73549090156     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181b8fc88     Document Type: Article

References (25)

1. Ryerson AB, Benard VB, Major AC. The National Breast and Cervical Cancer Early Detection Program 1991-2002 national report. Atlanta (GA): Department of Health and Human Services; 2005.
2. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, et al. Comparison of screening mammography in the United States and the United Kingdom [published erratum appears in JAMA 2004;291:824]. JAMA 2003;290:2129-2137
3. Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, et al. Breast cancer screening among lowincome or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control 2006 Feb;17:29-38.
4. Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998-2001. Obstet Gynecol 2007;110:681-686
5. 5. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N EnglJ Med 2003;349:1501-1509 (Pubitemid 37255035)
6. Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol 2004;103:564-571
7. 7. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 2005;105:1323-1328 (Pubitemid 40734264)
8. 8. Cooper CP, Saraiya M, McLean TA, Hannan J, Liesmann JM, Rose SW, et al. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) 2005;14:670-678 (Pubitemid 41645628)
9. 9. Saraiya M, Irwin KL, Carlin L, Chen X, Jain N, Benard V, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 2007;110:1024-1032 (Pubitemid 47312868)
10. 10. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129 (Pubitemid 34437347)
11. Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG 2002;109:364-368
12. Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol 1990;97: 859-861
13. 13. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390 (Pubitemid 34493201)
14. Wright TC Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. AmJ Obstet Gynecol 2007;197:346-355
15. Ferris DG, Wright TC Litaker MS, Richart RM, Lorincz AT, Sun XW, et al. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?J Fam Pract 1998;46:125-134
16. Solomon D. Chapter 14: role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr 2003;31:97-101.
17. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
18. Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, et al. Activity level and process indicators of organised programmes for cervical cancer screening in Italy. Epidemiol Prev 2006;30(1 Suppl 3):27-40.
19. Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Lestani M, et al. The risk of false-positive histol- ogy according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trial. AmJ Clin Pathol 2008;129:75-80.
20. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test J Natl Cancer Inst 2008;100:492-501.
21. 21. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006;7:547-555 (Pubitemid 43923665)
22. Tangka FK, Dalaker J, Chattopadhyay SK, Gardner JG, Royalty J, Hall IJ, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control 2006;17:1145-1154
23. 23. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004;36:11-19 (Pubitemid 38252839)
24. Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008;112:626-635
25. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/lowgrade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst 2006;98:92-100.